FRI0421 DYSREGULATED MIR-125 PROMOTES JOINT ANGIOGENESIS IN PSA THROUGH ALTERED BIOENERGETICS
Background: Psoriatic arthritis (PsA) is characterised by an early vascular phase which is essential in perpetuating pannus growth, immune responses and disease progression. Recently, numerous studies have highlighted the emerging importance of endothelial cell metabolism in controlling angiogenesis. Herein, we propose microRNA, miR-125, modulates EC bioenergetics and orchestrates joint angiogenesis as characterised using ex-vivo and in-vitro tissue/cell assays and a novel in-vivo zebrafish model. Objectives: To examine the relationship between miR-125, angiogenesis and cellular metabolism in the PsA synovium. Methods: Primary PsA synovial fibroblasts (PsA FLS) and microvascular endothelial cells (HMVEC) were transfected with anti-miR-125a. Angiogenic mechanisms were quantified using tube formation assays, invasion by Transwell Matrigel chambers, migration by wound repair and metabolic gene expression by RT-PCR. Real-time analysis of extracellular acidification rates (ECAR) and oxygen consumption rates (OCR) of anti-125 treated HMVEC was assessed using the XF-24 Flux Analyzer (Seahorse Bioscience). To determine if altered metabolism is observed ex vivo, glycolysis/oxidative phosphorylation markers (GAPDH/PKM2/GLUT1/ATP), and angiogenic factors (FactorVIII/VEGF/ANG2) were quantified by immunohistology. MiRNA levels were quantified in synovial tissue (ST) and PBMC by RT-PCR and compared to clinical marker and immunohistochemical analysis. The angiogenic effects of miR-125 were assessed in vivo using GFP-tagged zebrafish embryos treated with anti-125 morpholinos, or vitamin D3 analog, calcitrol, to monitor vascular development. Results: An increase in tube formation, cellular invasion and/or migration mechanisms (p<0.05) were demonstrated in anti-miR-125a transfected HMVEC and FLS supernatant. Inhibition of miR-125 significantly decreased basal, maximal and spare respiratory capacity (P<0.009) with a concurrent decrease in ATP synthesis (P<0.008). Increased glycolysis was further confirmed by the observed elevation of glycolytic genes: HK2, GSK3A, PDK1, HP6G (ns) and 3PO target and stimulator of glycolysis, PFKFB3 (P<0.05). In vivo synovial expression of miR-125 was significantly decreased in PsA versus OA synovial tissue and was associated with increased PsA macroscopic and microscopic vascularity. This was paralleled by a significant increase in the vascular expression of glycolytic markers, PKM2, GLUT1 and ATP5B in PsA compared to OA synovium. Finally, anti-125 morpholinos treated Zebrafish displayed increased vascular sprouting. In contrast, Calcitriol significantly reduced vascular development and increased the expression of miR-125, promoting miR-125 as a potential mechanism for orchestrating angiogenic development in vivo and in response to pharmaceutical agents Background: Spondyloarthritis (SpA) are an inflammatory joint disease with chronic, progressive, axial inflammation of the spine and the sacroiliac joints. Diagnosis of SpA is done criteria by clinical symptoms, radiology and MRI or ultrasound following ASAS criteria. AS is similar to rheumatoid arthritis (RA) and psoriatic arthritis (PsA) as they are all inflammatory joint disease. Nevertheless they show considerable different pathology.
[1] Objectives: The aim of our study is to test whether a novel assay that we developed for RA can be used for SpA diagnosis. We have previously showed that antibodies to oxidative post-translationally modified collagen type II (oxPTM-CII) are present specifically in RA patients whether ACPA positive or negative.
[2] Our study intends to investigate the reactivity to oxPTM-CII in SpA patients in comparison to early undifferentiated arthritis (EUA) and PsA patients. Methods: oxPTM-CII were generated using ribose and various reactive oxidants, and then they were analysed by SDS-PAGE. Binding to native and oxPTM-CII was evaluated by ELISA and Western Blotting. We used a cohort of sera from 67 patients with SpA, 54 patients with PsA, 49 patients with EUA. As control we used 19 patients with fibromyalgia (FM) and 70 healthy subjects. The specificity of the binding was further assessed by competitive ELISA and western blot. Results: We detected stronger reactivity to SpA compared to PsA and even EUA serum samples. Hence specific binding to oxPTM-CII was seen in the 52% of SpA sera compared to 12% in PsA and 10% in EUA. Active peripheral arthritis and extra-articular manifestations may influence the presence of circulating MAIT cells in AS. Objectives: To investigate circulating MAIT cells in a homogenous group of axial spondyloarthritis (SpA) patients with only axial involvement in comparison to ageand sex-matched healthy controls (HC). Secondly, to explore the association of MAIT cells with symptom duration and disease activity. Methods: Consecutive axial SpA patients from the Groningen Leeuwarden axial SpA (GLAS) cohort without active peripheral arthritis, inflammatory bowel disease, psoriasis or uveitis were included. Patients with active infections or current use of biologics were excluded to rule out possible influence on the presence of circulating MAIT cells. Disease activity was assessed using ASDAS, BASDAI, and serum CRP levels. The frequencies and absolute numbers of circulating MAIT cells were examined in peripheral blood of all studied samples by 5-color flow cytometry. Immediately after sampling, EDTA-blood was stained with anti-CD3, anti-CD8, anti-TCRVa7.2, anti-CD161, and anti-TCRgd. After staining, the cells were washed, fixed, and analyzed immediately on FACS. MAIT cells were identified phenotypically as CD3 + CD8 + TCRγδ -Vα7.2 + CD161 high cells. Results: Of the 41 included axial SpA patients, mean age was 46±16 years, 73% were male, mean symptom duration was 23±14 years, and 78% were HLA-B27 positive. Mean ASDAS was 2.6±1.0, mean BASDAI was 4.4±2.5, and median CRP was 3 (range 2-30). 70%, 54% and 37% of axial SpA patients had ASDAS ≥2.1, BASDAI≥4 or CRP≥5, respectively. HC had exactly the same age and sex distribution. Both the percentages and absolute numbers of circulating MAIT cells were comparable between axial SpA patients and HC (Figure 1) . In axial SpA patients, absolute numbers of MAIT cells correlated negatively (rho=-0.339) with symptom duration. No significant associations were found between MAIT cells and disease activity, except for a negative correlation (rho=-0.332) between frequency of MAIT cells and BASDAI (Table 1 ). There were no significant differences in MAIT cells between axial SpA patients with and without active disease according to ASDAS, BASDAI or CRP. Background: Ankylosing spondylitis (AS) is characterized by inflammation within the sacroiliac joints and at the spine including vertebral bodies and facet joints. In AS, bone destruction is followed by new bone formation leading to ankylosis of joints and syndesmophyte development. Histological studies of bone material from AS patients showed subchondral bone marrow changes, namely the transition of the bone marrow into granulation tissue which facilitates subchondral bone destruction but also promotes local bone formation [1, 2] . Currently, it is unclear what promotes the transition of the bone marrow into the granulation tissue. Objectives: The aim of this study was to look for changes in the subchondral bone marrow in joints from AS patients that may precede and promote transformation into granulation tissue. Therefore, we analyzed the cellular composition of the bone marrow and determined local cytokine expression at subchondral regions of AS facet joints. Methods: Facet joints were acquired from AS patients undergoing polysegmental correction surgery and compared to joints from autopsy controls. We performed immunohistochemical stainings to determine the number of T cells (CD3) and B cells (CD20), macrophages (CD68, CD163), monocytes (CD14), dendritic cells (DC; CD1a, DCsign) and myelopoietic cells (MPO). To correct for putative differences in fat cell content, software assisted image analysis was used to calculate the area of bone marrow covered by fat cells and the number of nucleated cells (DAPI) as well as myeloid cells. Cytokine expression was determined by mRNA in situ hybridization (TNF, IFNg) or immunohistochemistry (TGFβ, IL-10). Results: We observed no difference in the number of adaptive immune cells, i.e. CD3+ T and CD20+ B cells, between AS and control joints and found no difference in T/B cell aggregates. Furthermore, no difference in the number of macrophages (CD163+, CD68+) and DCs (CD1a+, DCsign+) was found. The only difference in cellular composition appeared to be a slight trend towards a higher percentage of myelopoietic MPO+ cells/DAPI+ cells in AS joints compared to control joints. The overall number of DAPI+ cells as well as the fat content of the bone marrow was not different between AS and control joints. Concerning cytokines, TNF mRNA expression was in general low but significantly increased (p<0.05) in AS versus control joints. No difference was found for IFNg. The number of TGFβ expressing cells was similar in AS and control joints while the number of IL-10 positive cells was decreased (p<0.01) in AS joints.
Conclusions:
The results show a shift from pro-inflammatory to anti-inflammatory cytokine expression within subchondral bone marrow sites in AS joints while no major change in the cellular distribution of the major leukocyte subsets is found. The shift in cytokine milieu may contribute to transformation of the bone marrow into granulation tissue. It would be interesting to determine the cellular source of local cytokines, such as of IL-10. Background: IL23 binding to IL23 receptor (IL23R) is necessary for the maturation of Th17 cells and generation of proinflammatory IL17 and TNF in AS. IL23R variants have considerable impact on AS susceptibility in genome-wide association studies. Objectives: To describe the effect of genotypic IL23R variants on proinflammatory cytokines and disease measures in AS. Methods: Cross sectional cohort study of patients with established AS (n=334, 90% B27 +, mean age at study 45 years) included in a disease registry. IL23R genotyping for nonsynonymous SNP's (rs11209026 (protective allele A) and rs11209032 (risk allele A) was done by Taqman RT-PCR, while IL23, IL17, IL6 and TNF levels determined by sandwich ELISA and compared with age and gender matched healthy controls (n=72). Genotypic associations with clinical and serological features were analyzed with nonparametric methods. Results: There was no significant difference between in AS patients and controls
